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http://dx.doi.org/10.1016/j.kjms.201Abstract Pulmonary vein isolation and atrial substrate modification using catheter ablation
have been developed as a standard treatment for atrial fibrillation (AF). However, the standard
end-point for these procedures is still not well established. This study aimed to investigate the
characteristics among positive and negative AF vulnerability patients with normal structural
heart, in order to define the endpoint of the atrial substrate modification. Fifty supraventric-
ular tachycardia patients with normal heart structure referred for electrophysiological study
and catheter ablation were enrolled. After eliminating the underling arrhythmias, the basic
cycle length, effective refractory period of the right atrium, and the P wave indices in 12-
lead electrocardiograms were measured. The AF vulnerability test was performed by atrial
burst decremental pacing with a pacing cycle length decreasing from 290 ms to 200 ms. The
AF vulnerability test was considered as positive when the duration of the induced AF or atrial
tachyarrhythmias (ATs) was longer than 10 seconds. The parameters of atrial substrates were
compared between patients with positive and negative values of the AF vulnerability test. ATs
or AF were induced in 24 (48%) patients. Among these patients, 12 (24%) induced ATs or AF
were found to be sustained (duration more than 10 seconds). However, only two of these
patients could reproduce the positive result after 10 minutes of the first induced protocol.
Comparing the patient baseline characteristics, P wave characteristics and cardiac echo
parameters, there were no significant differences between the positive and negative AF
vulnerability groups. In conclusion, AF and ATs could be induced in patients with a structurally
normal heart. The traditional clinical indices of atrial substrates were not significantly
different between the positive and negative AF vulnerability patients. Protocols other thanlar Center, Kaohsiung Medical University Hospital, No 100 Tzyou 1 Street, Kaohsiung 80708, Taiwan.
com.tw (K.-T. Lee).
hsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
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300 W.-H. Tang et al.atrial burst decremental pacing should be investigated to evaluate the endpoint of the atrial
substrate modification.
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Initiating triggers and atrial substrates are the two major
components contributing to the occurrence and mainte-
nance of atrial fibrillation (AF) [1,2]. Elimination of initi-
ating triggers and maintenance of atrial substrates are two
important strategies for management of AF [3,4]. Catheter
ablation with pulmonary veins isolation and atrial
substrates modification can eliminate the initiating triggers
and modify the atrial substrates for maintenance of AF, and
have been developed as a treatment strategy for patients
with symptomatic, drug-refractory AF [3,4]. However, the
end-point of catheter ablation of AF has not been clearly
established.
Previous studies have reported that noninducibility of
atrial tachyarrhythmias (ATs) after catheter ablation was
a good predictor of a low recurrence rate of AF after
pulmonary vein isolation [5,6]. However, ATs could also be
induced in patients who had atrioventricular nodal re-entry
tachycardia (AVNRT) or atrioventricular reciprocating
tachycardia (AVRT) with or without history of AF [7]. The
mechanisms of the inducibility test and its relationship to
the atrial substrates are still not totally understood [7,8].
The purpose of this study was thus to investigate the
characteristics of atrial substrates among positive and
negative AF vulnerability test patients with normal struc-
tural heart, in order to definite the endpoint of the atrial
substrate modification.
Materials and methods
Study participants
Fifty patients with paroxysmal supraventricular tachycar-
dias (PSVT) referred for electrophysiological study and
catheter ablation were enrolled. All patients had a detailed
review of their disease history. The dimensions of the left
atrium (LA) and left ventricle (LV), and the ejection frac-
tion (EF) of the LV were measured by transthoracic echo-
cardiography according to the American Society of
Echocardiography guidelines [9]. No evidence of AF
according to data from Holter electrocardiography
recording and from detailed symptoms suggesting AF could
be detected in any patient.
Electrophysiological study and catheter ablation
All patients received electrophysiological study and cath-
eter ablation in a postabsorptive, nonsedated state after
informed consent was obtained. All antiarrhythmic drugs
were discontinued for at least five half-lives before the
electrophysiological study. Three multipolar electrodecatheters were positioned in the high right atrium, His-
bundle area, and right ventricle, via the right femoral vein.
One decapolar electrode catheter was introduced from the
right internal jugular vein and placed in the coronary sinus
to record the electrical activity around the posteroseptal
area and coronary sinus. Intracardiac bipolar electrograms
and 12-lead electrocardiogram (ECG) were displayed and
recorded by a computer recording system (Bard LabSystem
PRO EP Recording System version; Bard, Electrophysiology
Division, Lowell, MA, USA) for further analysis. A pro-
grammed electrical stimulator (DTU-210; Bloom Associates,
Reading, PA, USA) was used to deliver electrical impulses of
2.0-ms duration at approximately twice the diastolic
threshold. The mechanisms of PSVT were determined by
criteria proposed by previous reports [10,11]. Catheter
ablation was performed after diagnosis of mechanisms of
PSVT. Techniques used for catheter ablation were the same
as described in previous reports [10,11].
AF vulnerability test
After the catheter ablation, the AF vulnerability test was
performed. Continuously decremental atrial pacing from
HRA with a pacing cycle length decreasing from 290 ms to
200 ms was performed on the patient in order to induce AF
or ATs. The positive AF vulnerability test was considered
significant when the duration of the induced AF or ATs was
longer than 10 seconds. In order to prevent the effect of
acute atrial electrical remodeling by rapid atrial pacing,
the test was measured repeatedly three times after
10 minutes rest to determine the reproducibility of the
results.
Measurements of the effective refractory period
and P wave indices
The effective refractory period (ERP) of the right atrium,
the P wave indices in each lead of the surface ECG and the
sinus cycle length for each patient were measured
according to previous study definition after catheter abla-
tion [12]. The ERP of the right atrium was measured by
introducing the S2 extrastimulus after eight regularly paced
S1eS1 at a basic pacing cycle length of 400 ms. The ERP of
the right atrium was then defined as the longest S1eS2
interval when the S2 could not be captured by the atrium
tissue.
The P wave indices including the P waver duration,
P wave amplitude, and P wave duration dispersion (PWD)
were measured manually by digital caliper at a sweep
speed of 50 mm/second and amplified 32 times on
a computer recording system. The onset of the P wave was
defined as the point of first upward slope from baseline for
positive wave and as the point of first downward slope from
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defined as the return to baseline. The mean duration of
P wave in each lead of ECG was obtained by measuring
P wave duration of three consecutive sinus beats. The PWD
was defined as the difference between the mean maximum
P wave duration and the mean minimum P wave duration in
the 12-lead ECG. The amplitude of P wave was measured by
peak amplitude of P wave in a monophasic P wave and
peak-to-peak amplitude in a biphasic P wave. The mean
amplitude of P wave in each lead was obtained by
measuring P wave amplitude of three consecutive sinus
beats.
Clinical follow-up
All studied patients received regular follow-up at the
outpatient clinic. All possible symptoms and signs suggest-
ing the attack of tachyarrhythmia were surveyed and
recorded. The 12-lead surface ECGs were examined and
reviewed in the follow-up visits.
Statistical analysis
All data are expressed as mean  S.D. Continuous variables
in the two groups were compared using an independent
t test. Noncontinuous variables in the two groups were
compared using the Chi-square test. A p value of <0.05 was
considered significant. All statistical operations were per-
formed using SPSS software (version 11.0, SPSS Inc, Chi-
cago, IL, USA).
Results
Fifty patients (24 males) with PSVT were enrolled in this
study. The mean age of the patients was 46  14 years.
Among these patients, only seven had hypertension and
none had diabetes mellitus or other systemic diseases. TheTable 1 Comparisons of the baseline characteristics, P wave m
Variable Positive AF vulnerability
group (n Z 12)
Sex (M:F) 5:7
Age (y) 45  17
Hypertension 1
BCL (ms) 746  156
Atrial ERP (ms) 240  14
Pmax (ms) 121  8
PWD (ms) 28  14
Vmax (mV) 0.14  0.05
LAd (mm) 30  7
LVEDD (mm) 45  4
LVSd (mm) 10  2
LVEF (%) 62  9
AVNRT Z atrioventricular nodal reentry tachycardia; AVRT Z a
ERPZ effective refractory period; IVSdZ thickness of the interventr
diastolic dimension of the left ventricle; LVEF Z Left ventricular
PSVTZ paroxysmal supraventricular tachycardia; PWDZmean P wavemean value of the patients’ LA, LV end diastolic dimension
and the LVEF were calculated as 33  6 mm, 45  5 mm and
69  10% respectively.
Thirty-three patients were diagnosed AVNRT and 17
AVRT after the complete cardiac electrophysiology study.
All patients then received successful catheter ablation with
no recurrence noted in follow-up visits.
From the electrophysiological studies, the mean of the
basic sinus cycle length, the right atrium ERP, the maximal
mean P wave duration and the mean PWD were calculated
as 767  135 ms, 234  23 ms, 124  12 ms, and 34  13 ms,
respectively. The mean maximal amplitude of P wave was
0.13  0.04 mV.
After catheter ablation, continuously decremental
pacing from pacing cycle length from 290 to 200 ms was
performed. A nonsustained AF or ATs was induced in 24
(48%) patients in which 17 patients were AVNRT and seven
patients were AVRT. The duration of the induced ATs varied
from 936 ms to 185,481 ms. However, only 12 (24%) patients
whose induced AF or ATs lasted more than 10 seconds were
considered as positive AF vulnerability. After 10 minutes of
rest, the identical stimulation protocol was performed
again to evaluate the reproducibility of the results. Inter-
estingly, after 3 repeated tests, the sustained ATs or AF
could only be reinduced in two out of 12 of the previous
positive patients.
In Table 1, the characteristics of the positive and
negative AF vulnerability test patients are compared and
demonstrated. The distributions of sex and hypertension
were not significantly different between patients with and
without significant inducibility of ATs. There were also no
significant differences in basic sinus cycle length (746  156
vs.774  130 ms, p Z 0.5), ERP of RA (240  14 vs.
246  18 ms, pZ 0.6), the mean maximal P wave duration
(121  8 vs. 125  13 ms, pZ 0.3), the mean PWD (28  14
vs. 36  12 ms, pZ 0.07), mean maximal P wave amplitude
(0.14  0.05 vs. 0.13  0.04 mV, pZ 0.5), dimension of the
left atrium (30  7 vs. 33  6 mm, pZ 0.4), or end-diastolicorphology and cardiac echo parameters.
Negative AF vulnerability
group (n Z 38)
p
19:19 0.5
46  13 0.7
6 0.7
774  130 0.5
246  18 0.6
125  13 0.3
36  12 0.07
0.13  0.04 0.5
33  6 0.4
45  5 0.9
9  2 0.6
70  10 0.4
trioventricular reciprocating tachycardia; CL Z cycle length;
icular septum; LadZ dimension of the left atrium; LVEDDZ end
ejection fraction; Pmax Z maximal mean duration of P wave;
duration dispersion; VmaxZmaximal mean amplitude of P wave.
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LVEF (62  9 vs. 70  10%, p Z 0.4) between the positive
and negative AF vulnerability groups.
The mean duration of follow-up was 18  9 months after
catheter ablation. No patient had an ECG recording or
symptoms suggesting significant tachyarrhythmia occurring
during follow-up.Discussion
In this study, AF or ATs could be induced in almost half (24/
50 patients, 48%) of our patients with PSVT and without AF
history after catheter ablation. However, only 24% of these
induced ATs could be sustained longer than 10 seconds and
the reproducibility of the results was low. Comparing RA
ERP, sinus cycle length, maximal P wave duration, PWD,
maximal amplitude of P wave, and echocardiographic
parameters showed no significant difference between the
positive and negative AF vulnerability groups. Of note, all
patients had no evidence of significant tachyarrhythmia
occurring during clinical follow-up.
Mechanisms of ATs have been proposed in previous
studies [1,2]. Atrial substrate was believed to play an
important role in the maintenance of ATs including AF.
Many indices of atrial substrates, including ERP of the
atrium, P wave duration, and PWD, have been suggested to
be associated with property of atrial activation [13e16].
The heterogeneous changes of ERP in different areas of
atrium were reported in patients with AF [17]. Longer P
wave duration and the wider PWD were reported to be
correlated with a longer and more heterogeneity of atrial
activation and associated with more frequent occurrence of
AF [16,18]. Furthermore, previous studies also demon-
strated that older age, larger LA and impairment of LV
function were associated with the occurrence of AF [19,20].
In this study, however, no indices of atrial substrates
showed significant difference between patients with and
without inducible ATs. The inducibility of the ATs or AF in
our patients could not be predicted from the conventional
atrial substrates indices used generally. As a result, further
studies are needed to clarify the mechanisms involved in
the inducibility of ATs in structural normal heart
individuals.
All patients enrolled in this study had no evidence of
other symptomatic ATs except PSVT. After elimination of
the clinical documented PSVT, ATs were induced in 48% of
patients by the atrial decremental pacing protocols.
However, only 24% of these induced ATs could be sustained
for longer than 10 seconds and the reproducibility of the
results occurred in only 2/12 (17%) of the patients. This
raises the question of what are the meanings and the
significance of the ATs inducibility test (which is also
frequently used as the AF vulnerability test) after AF
catheter ablation.
Previous clinical studies have observed the relatively
frequent occurrence of symptomatic AF in patients after
successful catheter ablation of atrioventricular accessory
pathways and found that older age and atrial vulnerability
were the two independent predictors of AF occurrence
[8,21]. Dagres et al. also demonstrated that old age, but
not inducibility of AF, was a predictor of recurrence of AF inpatients after catheter ablation of atrioventricular acces-
sory pathway [8]. By using various different pacing proto-
cols, Huang et al. also reported that about 27% of the PSVT
patients without AF history could experience induced AF
during cardiac electrophysiological study [22].
Pulmonary vein isolation and atrial substrate modifica-
tion using catheter ablation have been developed to be one
of the modalities to treat patients with drug-refractory,
symptomatic AF. However, the reliable end-point of AF
ablation is still not well defined. Previous studies demon-
strated that noninducible ATs could predict the freedom
from AF after catheter ablation [5,6]. A stepwise strategy
for AF ablation using the inducibility as a guide for further
ablation, has been proposed [6]. This stepwise strategy
prevents the proarrhythmia induced by more advanced
catheter ablation, which suggests that ATs need adequate
atrial substrates for their maintenance. However, in the
stepwise ablation strategy, further stepwise line ablation
procedures may also ablate the autonomic nervous plexus
and therefore modulate the autonomic function, which
could be another mechanism to explain the improvement of
the success rate of AF ablation other than substrate modi-
fication [23]. As a result, the clinical significance of the ATs
inducibility test and its relationship to AF vulnerability both
need more investigation to validate the claim.
There were many factors that might interfere with the
result of inducibility of ATs during electrophysiological
study, including: (1) site of the stimulation; (2) autonomic
tone status of patients; (3) pacing protocol; and (4) the
degree of the provocative tests.
The AF vulnerability test is usually performed after the
AF pulmonary vein isolation and substrate modification to
test the atrial substrate condition. Most of our patients in
this study were AVNRT or AVRT; spot ablation was per-
formed using 4 mm tip ablation catheter and limited atrial
tissue was injured during the procedure. However, Chang
et al. also showed that there was a different effect of atrial
vulnerability and remodeling after the AF ablation between
AF patients with AVNRT and AVRT [24]. The complexity of
the relationship between the AF, PSVT, and decremental
atrial burst pacing need to be further clarified.
In our study, the traditional indices of atrial substrates
could not predict the inducibility of ATs. This result also
suggested that the mechanisms of inducibility of ATs in
those patients without history of AF might be different from
those patients with clinically documented AF.
There are some limitations concerning this study that
are worth noting. First, there was only one inducibility
protocol used in our study; different protocols may result in
different results. Second, the period of clinical follow-up
was relatively short. Third, the patients enrolled in our
study had no history of organic heart disease or AF. The
results of this study cannot completely be applied to
patients with AF or with organic heart disease.
In conclusion, ATs or AF could be induced in the patient
with normal structural heart. The traditional clinical
indices of atrial substrates were not significantly different
between the positive and negative AF vulnerability groups
in our patients. Protocols other than atrial burst decre-
mental pacing should be investigated to evaluate the
endpoint of the atrial substrate modification in catheter
ablation of AF or other ATs.
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